97至尊品牌源于信誉(有限公司)官方网站-Weixin百科

Privacy settings

This website may store cookies on your browser. Cookies are mostly used to make the website work as you expect it to. No cookie will directly identify you, but it can give you a more personalized browsing experience.

Endovastec respects your privacy rights, so you can block some types of cookies. Technically non-essential cookies and tracking mechanisms, that enable us to provide you with customized offers (marketing cookies), are only used if you have given prior consent to such use.

Strictly necessary cookies

Consent to marketing cookies

By clicking "Save", only the cookies you selected will be used. You can with draw the consent that you granted here at any time by going to Cookies Settings. For more information, please see our Cookie Policy.

Consent to marketing cookies

Save

Stock Code

688016.SH

Product Introduction

Ryflumen™ Peripheral High-pressure Balloon Dilatation Catheter is indicated for percutaneous transluminal angioplasty (PTA) of the peripheral vascular system, including the iliac, femoral, popliteal, tibial, peroneal, subclavian, and renal arteries, as well as for the treatment of occlusive lesions in arteriovenous fistulas for autologous or artificial dialysis, and for the postdilatation of balloon-expandable stents or self-expanding stents in the peripheral vascular system.

Specification Parameter

About us

News

Company News

Products

Patients

Investor Relations

Join Us

Telephone:(86) (21) 38139300

Address:Building #1,3399 Kangxin Rd., SIMZ Century Medicine Park, Shanghai201318,P.R. China

Fax:(86) (21) 33750026

WeChat

Internet Drug Information Service Qualification Certificate No.: (Hu) - Non-operating -2024-0188

Website record/ license No.：沪ICP备14048493号-1 备案.png HGWA Bei No.31011502014536

The registered trademarks of “微创", "MicroPort" and"" are registered trademarks of Shanghai MicroPort Medical (Group) Co., Ltd., they have been authorized to be used by Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd., and no other party shall use such trademarks without prior written permission thereof.